ERAP2 and urinary bladder carcinoma: Expression of ERAP2 (endoplasmic reticulum aminopeptidase 2), a pan-cancer gene associated with MHC-I antigen processing, predicted survival in bladder cancer patients receiving ICI therapy (120).